Abstract:[Objective]To study the significance of expression changes of bone morphogenetic protein 4 (BMP4) and mothers against decapentaplegic homolog 4 (SMAD4) in the diagnosis of glioma.[Methods]45 samples of glioma and 10 samples of normal brain tissue were collected randomly. The expressions of BMP4 and SMAD4 were detected with RT-PCR and Western blot.[Results]RT-PCR results showed:compared to the normal brain tissue,the expression of BMP4 in low-grade gliomas and high-grade gliomas was reduced by (23.5±0.23) % and (46.6±0.34) %,and the difference was significant (P<0.05). The expression of SMAD4 was reduced by (30.6±0.41) % and (95.3±1.02) % respectively (P<0.05). Western blot results showed:compared to the normal brain tissue,the expression of BMP4 was reduced by (28.4±0.25) % and (80.4±1.05) % respectively (P<0.05),the expression of SMAD4 was reduced by (76.8±1.15) % and (96.2±2.01) % respectively,and the difference was significant (P<0.05).[Conclusion]BMP4 and SMAD4 may be related to the occurrence,development and malignant degree of glioma. BMP4 and SMAD4 can be regarded as an important index in the diagnosis and classification of glioma.

Significance of Bone Morphogenetic Protein 4 and SMAD 4 in the Diagnosis of Glioma